4//SEC Filing
INTERPHARM HOLDINGS INC 4
Accession 0001239119-06-000001
CIK 0000893970operating
Filed
Jul 12, 8:00 PM ET
Accepted
Jul 13, 3:30 PM ET
Size
9.1 KB
Accession
0001239119-06-000001
Insider Transaction Report
Form 4
RAMETRA MONA
10% Owner
Transactions
- Conversion
Series K Convertible Preferred Stock
2006-05-25+292,214→ 0 total→ Common Stock - Conversion
Common Stock
2006-05-25+6,274,780→ 2,022,823 total
Holdings
- 8,014,928(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]On May 25, 2006, Rametra Holdings I, LLC, a New York limited liability company of which Mona Rametra is the sole member, converted an aggregate of 292,214 shares of Interpharm Holdings, Inc. ("Interpharm") Series K Convertible Preferred Stock ("Series K Stock") into an aggregate of 6,274,780 shares of Common Stock of Interpharm ("Common Stock"), at a conversion rate of approximately 21.47 shares of Common Stock issued for each share of Series K Stock converted.
- [F2]On June 4, 2004, all conditions for the conversion of the Series K Stock were met, making that date the "Trigger Date" as defined in the Certificate of Designations of the Series K Stock. After the Trigger Date, the Series K Stock was to convert ratably, over a seven year period. One-seventh of the outstanding shares of Series K Stock converted into Common Stock on each of June 4, 2004 and June 4, 2005, at a conversion rate of approximately 21.47 shares of Common Stock issued for each share of Series K Stock converted. On May 25, 2006 Interpharm and the holders of all of the outstanding shares of Series K Stock, including Rametra Holdings I, LLC, agreed that all of the hares of Series K Stock then outstanding would immediately convert into Common Stock at the same conversion rate.
Documents
Issuer
INTERPHARM HOLDINGS INC
CIK 0000893970
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000893970
Filing Metadata
- Form type
- 4
- Filed
- Jul 12, 8:00 PM ET
- Accepted
- Jul 13, 3:30 PM ET
- Size
- 9.1 KB